ASND ▲ +2.2% - Ascendis Pharma A/S
$ASND reported Q3 2026 Adj EPS of $1.97, beating the $1.13 estimate by 74.2%. Revenue of $425.4M beat the $417.2M estimate by 2.0%.
12-NOV-2026 07:40 AM ET
Share this post
More filings for $ASND
ASND ▲ +2.2% - Ascendis Pharma A/SNov 12, 2026ASND ▼ -1.3% - Ascendis Pharma A/SNov 10, 2026ASND ▲ +0.0% - Ascendis Pharma A/SNov 6, 2026ASND ▼ -1.8% - Ascendis Pharma A/SNov 5, 2026ASND - Ascendis Pharma A/S - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ASND ▲ +0.1% - Ascendis Pharma A/SOct 16, 2026
View full $ASND filing history →💬 Comments
Loading comments…
Leave a comment